MKM Partners Hires Healthcare Specialist

Jun 14 2011 | 8:28am ET

Stamford-based MKM Partners has hired Jon LeCroy, M.D., as managing director in its equity research department covering biotechnology and specialty pharmaceuticals companies. The hire marks the beginning of the company’s expansion into the healthcare sector.

LeCroy has covered the same sector at Goldman Sachs, Natixis Bleichroeder and, most recently, at Hapoalim Securities USA. 

"Our move into the healthcare vertical expands MKM's research footprint," said MKM Partners CEO Richard R. Castellano. "Jon's in-depth and actionable research—and his stockpicking prowess—will make him a key resource for MKM's existing institutional equity client base and enable us to service new clients focused on investment opportunities in healthcare."

MKM Partners is an institutional equity research, sales and trading firm.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

Often seen as a passion project, or part of a philanthropic venture, rare and fine stringed instruments offer an exciting option to diversify one’s investment portfolio while providing an opportunity for an exceptional long-term investment.